Welcome to chemicalbook!
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook > Product Catalogue >API >Nervous system drugs >Other nervous system drugs >Pentobarbital sodium

Pentobarbital sodium

Pentobarbital sodium Structure
  • ₹0
  • Product name: Pentobarbital sodium
  • CAS: 57-33-0
  • MF: C11H17N2NaO3
  • MW: 248.25
  • EINECS:200-323-9
  • MDL Number:MFCD00070198
  • Synonyms:Pentobarbital sodium salt,5-Ethyl-5-(1-methylbutyl)-2,4,6-trioxohexahydropyrimidine, Nembutal;2,4,6(1H,3H,5H)-PyriMidinetrione,5-ethyl-5-(1-Methylbutyl)-, sodiuM salt (1:1);barpe;PENTOBARBITAL SODIUM;5-ethyl-5-(1-methylbutyl)-2,4,6(1h,3h,5h)-pyrimidinetrionemonosodiumsalt ;5-Ethyl-5-(1-Methylbutyl)-;5-ethyl-5-(1-methylbutyl)barbituricacidsodiumsalt ;5-ethyl-5-(1-methylbutyl)-barbituricacisodiumsalt
Manufacturer Product number Product description Packaging Price Updated Buy

Properties

Melting point :127 °C (decomp)
solubility :H2O: soluble
form :Solid
color :Off-White
Water Solubility :Soluble to 100 mM in water
CAS DataBase Reference :57-33-0(CAS DataBase Reference)
EPA Substance Registry System :Pentobarbital sodium (57-33-0)

Safety Information

Symbol(GHS): GHS hazard pictograms
Signal word: Danger
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
H301 Toxic if swalloed Acute toxicity,oral Category 3 Danger GHS hazard pictograms P264, P270, P301+P310, P321, P330,P405, P501
Precautionary statements:
P264 Wash hands thoroughly after handling.
P264 Wash skin thouroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P301+P310 IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P321 Specific treatment (see … on this label).
P330 Rinse mouth.
P405 Store locked up.
P501 Dispose of contents/container to..…

Description

Barbituric acid, the precursor of barbiturates, was first produced in 1864 by condensation of malonic acid and urea; it had no central nervous system (CNS) effects. In 1903, diethyl barbituric acid (barbital) was created as the first barbiturate with CNS inhibitory effects. Barbiturates were commonly used as sedative-hypnotics in the mid-twentieth century; meantime they were abused by some people as sold on the street. Use of barbiturates quickly dropped after introduction of benzodiazepines as the safer sedative-hypnotics. However some of the barbiturates are still used as anticonvulsants and some for euthanasia.

Related product price